1. Home
  2. CUBI vs SLS Comparison

CUBI vs SLS Comparison

Compare CUBI & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

HOLD

Current Price

$80.76

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$13.78

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUBI
SLS
Founded
1994
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
CUBI
SLS
Price
$80.76
$13.78
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$85.00
$10.00
AVG Volume (30 Days)
190.9K
6.7M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
22.99
50.00
EPS
4.02
N/A
Revenue
N/A
N/A
Revenue This Year
$24.95
N/A
Revenue Next Year
$9.50
$110.98
P/E Ratio
$19.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.34
$1.39
52 Week High
$84.38
$15.88

Technical Indicators

Market Signals
Indicator
CUBI
SLS
Relative Strength Index (RSI) 49.62 53.11
Support Level $72.04 $11.43
Resistance Level $79.38 $15.77
Average True Range (ATR) 1.79 1.24
MACD -0.31 -0.06
Stochastic Oscillator 40.27 36.45

Price Performance

Historical Comparison
CUBI
SLS

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: